Clemson football players Braden Galloway and Zach Giella will not be eligible to play during the 2019 football season. The NCAA Committee on Competitive Safeguards denied the players’ appeal of the drug test they failed in December, the players’ attorney Robert Ariail announced Friday morning.
Before the College Football Playoff semifinal at the Cotton Bowl in December, Galloway, Giella and former starting defensive Dexter Lawrence tested positive on an NCAA-administered drug screening for trace amounts of ostarine, a banned anabolic substance typically utilized to generate lean muscle. The players were suspended from the Cotton Bowl against Notre Dame and the national championship game against Alabama.
Clemson announced plans to appeal the test results on Dec. 27. Lawrence left the program to pursue a career in the National Football League. He was drafted in the first round, 17th overall by the New York Giants.
According to a statement from Airail, during the appeal, Galloway and Giella argued that “they have no knowledge of how ostarine entered their bodies” and that both players passed polygraph tests. According to Airail, Galloway and Giella passed drug tests in April and October of 2018 and again in January and February of this year.
The players and their attorney asserted that the trace amounts were the result of contamination and presented statements from “scientific experts which confirmed that the very low levels detected in December 2018 were indicative of contamination of legitimate products.” During this appeal process, an independent lab tested 27 supplements and products and found no contaminants.
Click here to read more.
SOURCE: USA Today; The Greenville News, Manie Robinson